Cardiovascular atherosclerosis and percutaneous transluminal interventions

Mise à jour : Il y a 4 ans
Référence : ISRCTN12810677

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Background and study aims Atherosclerosis is the build-up of fatty material inside the arteries (blood vessels), which leads to heart attacks and strokes. It can be treated with a procedure called percutaneous coronary intervention (PCI), where a short wire-mesh tube, called a stent, is inserted into the artery to allow the blood to flow more freely. The aim of this study is to set up a registry (database) to follow the clinical outcomes of patients who have undergone PCI for atherosclerosis in order to improve the quality of patient care. Who can participate? Patients over 20 years old who have undergone PCI for atherosclerosis What does the study involve? Clinical data is collected about patients who underwent PCI at Chang Gung Memorial Hospital since November 1995. Deaths, heart attacks, and further stenting/surgery are all measured. The patients do not undergo any additional tests or treatment for the purposes of this study. What are the possible benefits and risks of participating? The results of this study may improve the quality of patient care. There are no risks involved. Where is the study run from? Chang Gung Memorial Hospital (Taiwan) When is the study starting and how long is it expected to run for? June 2011 to June 2021 Who is funding the study? Investigator initiated and funded Who is the main contact? Dr I-Chang Hsieh


Critère d'inclusion

  • Coronary disease receiving coronary artery stents

Liens